Amalgam Rx

Wilmington, United States

Amalgam Rx develops and distributes digital health products that support patients and healthcare providers in decision-making.

$7.9M raised

Aug 2025

Venture - Series Unknown

Top Investors

Catalio Capital ManagementNovo NordiskMentors FundCVS Health VenturesSupermorpheus

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Amalgam Rx raised?

Amalgam Rx has raised $7.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2025.

Who are Amalgam Rx's investors?

Amalgam Rx's investors include Catalio Capital Management, Novo Nordisk, Mentors Fund, CVS Health Ventures, Supermorpheus.

Where is Amalgam Rx headquartered?

Amalgam Rx is headquartered in Wilmington, United States.

What does Amalgam Rx do?

Amalgam Rx develops and distributes digital health products that support patients and healthcare providers in decision-making.

What stage is Amalgam Rx at?

Amalgam Rx is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 15, 2025.

MLA

"Amalgam Rx — Funding & Investors." VCBacked, August 15, 2025, https://www.vcbacked.co/company/amalgam-rx. Accessed June 8, 2026.

APA

VCBacked. (2025). Amalgam Rx — Funding & Investors. Retrieved June 8, 2026, from https://www.vcbacked.co/company/amalgam-rx

Wikipedia (cite web)

{{cite web |title=Amalgam Rx — Funding & Investors |url=https://www.vcbacked.co/company/amalgam-rx |website=VCBacked |access-date=June 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 15, 2025.